Nanovibronix Inc represents core values of innovation, excellence, and customer satisfaction. With a strong corporate philosophy focused on improving patients' lives through cutting-edge medical devices and solutions, Nanovibronix Inc sets itself apart in the healthcare industry. The company thrives on continuous research and development, delivering advanced technologies that address unmet clinical needs. Nanovibronix Inc's commitment to improving patient outcomes and its dedication to providing healthcare professionals with effective tools make it a trusted partner. With a passion for creating impactful solutions, Nanovibronix Inc consistently demonstrates its commitment to enhancing the quality of life for patients globally.

Nanovibronix Inc is primarily present in the United States and Israel.

Nanovibronix Inc has achieved significant milestones in its journey. The company has successfully developed and commercialized innovative medical devices, focused on pain management and wound healing. It has received FDA clearance and approvals for several of its groundbreaking products, including PainShield® and WoundShield™. Nanovibronix Inc has also established strategic partnerships and collaborations, further enhancing its market presence and global reach. The company's commitment to research and development has led to advancements in therapeutic ultrasound technology, improving patient outcomes and quality of life. Nanovibronix Inc continues to revolutionize the medical industry with its cutting-edge solutions and remains poised for future growth and success.

Nanovibronix Inc, a reputable company in the stock market, boasts a rich history and background. With a drive for innovation and technological advancements, Nanovibronix Inc specializes in the development of medical devices using low-intensity surface acoustic wave technology. Founded in [insert year], the company has continuously aimed to revolutionize the healthcare industry by providing non-invasive and cost-effective solutions for various medical conditions. Nanovibronix Inc has garnered recognition for its cutting-edge products, including PainShield® and WoundShield™, which have shown exceptional efficacy in pain management and wound healing. With a steadfast commitment to improving patient outcomes, Nanovibronix Inc remains at the forefront of medical device innovation.

The main competitors of Nanovibronix Inc in the market include companies such as Johnson & Johnson, Medtronic, Philips, and Siemens Healthineers.

Nanovibronix Inc primarily operates in the medical and healthcare industry.

Nanovibronix Inc operates under a business model that centers around the development and commercialization of innovative medical devices. The company specializes in utilizing proprietary low-intensity ultrasound technology for various therapeutic applications. Nanovibronix Inc's products aim to provide non-invasive and drug-free solutions for pain relief, wound healing, and infection control. By leveraging ultrasound technology, the company aims to offer cost-effective and convenient alternatives to traditional treatment methods. Nanovibronix Inc is committed to advancing healthcare through its cutting-edge devices, contributing to improved patient outcomes and overall well-being.

KGV za Nanovibronix trenutno ne može biti izračunato.

KUV za Nanovibronix trenutno ne može biti izračunat.

AlleAktien kvalitativni skor za Nanovibronix je 6/10.

Prihod trenutno ne može biti izračunat za Nanovibronix.

Profit trenutno ne može biti izračunat za Nanovibronix.

Nanovibronix Inc is a US-based company specializing in the development and manufacturing of medical devices and retail products. The company aims to develop and distribute innovative solutions for medical problems to help patients.

Nanovibronix isplaćuje dividendu od 0 USD raspoređenu preko isplata u toku godine.

Dividenda za Nanovibronix trenutno ne može biti izračunata ili kompanija ne isplaćuje dividendu.

ISIN od Nanovibronix je US63008J1088.

WKN od Nanovibronix je A2QB7C.

Oznaka za praćenje akcija kompanije Nanovibronix je NAOV.

U poslednjih 12 meseci, Nanovibronix je isplatio dividendu u iznosu od . To odgovara dividendnom prinosu od oko . Za narednih 12 meseci, Nanovibronix će verovatno isplatiti dividendu od 0 USD.

Dividendski prinos od Nanovibronix trenutno iznosi .

Nanovibronix isplaćuje dividende na kvartalnom nivou. One se isplaćuju u mesecima .

Nanovibronix je isplaćivao dividendu svake godine u poslednjih 0 godina.

Za narednih 12 meseci očekuju se dividende u iznosu od 0 USD. To odgovara dividendnom prinosu od 0 %.

Nanovibronix se svrstava u sektor 'Zdravlje'.

Da biste primili poslednju dividendu od Nanovibronix od 9. 7. 2024. u iznosu od 0 USD, morali ste da imate akciju u depou pre Ex-dana 9. 7. 2024..

Isplata poslednje dividende izvršena je 9. 7. 2024..

U godini 2023 kompanija Nanovibronix je isplatila 0 USD kao dividende.

Dividende od Nanovibronix se isplaćuju u USD.